Cytosorbents (CTSO) Property, Plant & Equipment (Gross) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Gross) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 25.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.63 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 7.74 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.55 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.47 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.69 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 4.11 Bn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | 12.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.98 Mn |
| Mar 31, 2026 | 12.98 Mn |
| Dec 31, 2025 | 12.97 Mn |
| Dec 31, 2025 | 12.97 Mn |
| Sep 30, 2025 | 13.48 Mn |
| Sep 30, 2025 | 13.48 Mn |
| Jun 30, 2025 | 13.46 Mn |
| Jun 30, 2025 | 13.46 Mn |
| Mar 31, 2025 | 13.31 Mn |
| Mar 31, 2025 | 13.31 Mn |
| Dec 31, 2024 | 13.23 Mn |
| Dec 31, 2024 | 13.23 Mn |
| Dec 31, 2023 | 13.09 Mn |
| Dec 31, 2023 | 13.09 Mn |
| Dec 31, 2022 | 12.64 Mn |
| Dec 31, 2022 | 12.64 Mn |
| Dec 31, 2021 | 9.91 Mn |
| Dec 31, 2021 | 9.91 Mn |
| Dec 31, 2020 | 6.37 Mn |
| Dec 31, 2020 | 6.37 Mn |
| Dec 31, 2019 | 5.58 Mn |
| Dec 31, 2019 | 5.58 Mn |
| Dec 31, 2018 | 4.90 Mn |
| Dec 31, 2018 | 4.90 Mn |
| Dec 31, 2017 | 4.26 Mn |
| Dec 31, 2017 | 4.26 Mn |
| Dec 31, 2016 | 3.23 Mn |
| Dec 31, 2016 | 3.23 Mn |
| Dec 31, 2015 | 3.10 Mn |
| Dec 31, 2015 | 3.10 Mn |
| Dec 31, 2014 | 2.70 Mn |
| Dec 31, 2014 | 2.70 Mn |
| Dec 31, 2013 | 2.55 Mn |
| Dec 31, 2013 | 2.55 Mn |
| Dec 31, 2012 | 2.51 Mn |
| Dec 31, 2012 | 2.51 Mn |
| Dec 31, 2011 | 2.49 Mn |
| Dec 31, 2011 | 2.49 Mn |